Publicaciones en las que colabora con Raúl Rodriguez Escobedo (14)

2023

  1. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Asturias (Spain) between 2011 and 2020: influence of symptom duration on prevalence of ketoacidosis and weight loss

    Revista espanola de salud publica, Vol. 97

  2. Incidence of type 1 diabetes mellitus in Asturias (Spain) between 2011 and 2020

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 3, pp. 189-195

  3. Pancreatic autoimmunity in the diagnosis of type 1 diabetes: usefulness of anti-zinc transporter 8 antibody and proposed stepwise assessment

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 4, pp. 286-288

  4. Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020

    Diabetology and Metabolic Syndrome, Vol. 15, Núm. 1

2022

  1. Cardiovascular diseases in people with diabetes mellitus in Spain according to the Primary Care Clinical Database (BDCAP) in 2017

    Medicina Clinica, Vol. 158, Núm. 4, pp. 153-158

  2. Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 493-499

  3. Efficacy in size and symptom reduction of radiofrequency ablation of benign non-functioning thyroid nodules

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 194-200

  4. Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 4, pp. 305-307

2021

  1. Efectividad y seguridad del tratamiento con iPCSK9 en vida real: experiencia de tres hospitales asturianos

    Semergen: revista española de medicina de familia, Núm. 6, pp. 369-375

  2. Primary adrenal leiomyosarcoma: a case report

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 7, pp. 516-517

  3. Real-life efficacy and safety of PCSK9 inhibitors treatment: Experience in three hospitals in Asturias

    Semergen, Vol. 47, Núm. 6, pp. 369-375

2020

  1. Diagnósticos de diabetes mellitus tipo 1 en el área sanitaria IV del Principado de Asturias en los años 2018 y 2019

    Universidad, investigación y conocimiento: el valor de la I+D+i para evolucionar hacia una sociedad sostenible y responsable (Universidad de Oviedo), pp. 437-444

2019

  1. Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2

    Medicina Clinica, Vol. 152, Núm. 11, pp. 438-441

  2. Experience after switching from insulin glargine U100 to glargine U300 in patients with type 1 diabetes mellitus. A study after one year of treatment in real life

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 4, pp. 210-216